Another article in NYTimes about Gilead: “ Gilead postponed a new version of an H.I.V. therapy, allowing the drugmaker to maximize profit on other products, documents showed.Credit...Thor Swift for The New York Times
It is my opinion the FDA is not happy with Gilead and that our little HIV summit is the start of our new relationship. Hold on to your hats. LH here we come